Mechanism of eNOS gene transfer inhibition of vascular smooth muscle cell proliferation

American Journal of Physiology - Cell Physiology

Volumn 284, Issue 1 53-1, 2003, Pages

  D'Souza, Fiona M ^a   Sparks, Rodney L ^a   Chen, Huiying ^a   Kadowitz, Philip J ^a   Jeter Jr , James R ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Adenoviral gene transfer; Aorta; Cell proliferation; Endothelial nitric oxide synthase; Nitric oxide

Indexed keywords

ADENOVIRUS VECTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; ANIMAL TISSUE; AORTA; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM; GENE TRANSFER; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALIA;

EID: 0037213571     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00179.2002     Document Type: Article

References (37)

1. Chamley-Campbell J, Campbell GR, and Ross R. The smooth muscle cell in culture. Physiol Rev 59: 1-61, 1979.
2. Champion HC, Bivalacqua TJ, D'Souza FM, Ortiz LA, Jeter JR, Toyoda K, Heistad DD, Hyman AL, and Kadowitz PJ. Gene transfer of endothelial nitric oxide synthase to the lung of the mouse in vivo. Circ Res 84: 1422-1432, 1999.
3. Chang MW, Barr E, Seltzer J, Jiang YQ, Nabel EG, Parmacek MS, and Leiden JF. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267: 518-522, 1995.
4. Clowes AW, Clowes MM, and Reidy MA. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 49: 327-333, 1983.
5. Clowes AW, Reidy MA, and Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest 49: 208-215, 1983.
6. Cornwell TL, Arnold E, Boerth NJ, and Lincoln TM. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol Cell Physiol 267: C1405-C1413, 1994.
7. Cornwell TL, Soff GA, Traynor AE, and Lincoln TM. Regulation of the expression of ryclic GMP-dependent protein kinase by cell density in vascular smooth muscle cells. J Vasc Res 31: 330-337, 1994.
8. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Rasking WH, and Reid BJ. A p53-dependent mouse spindle checkpoint. Science 267: 1353-1356, 1995.
9. Del Sal GD, Ruaro EM, Utera R, Cole CN, Levine AJ, and Schneider C. Gas1-induced growth suppression requires a transactivation-independent p53 function. Mol Cell Biochem 15: 7152-7160, 1995.
10. 1 arrest and apoptosis. Cancer Res 54: 1169-1174, 1994.
11. Fukuo K, Hata S, Suhara T, Nakahashi T, Shinto Y, Tsujimoto Y, Morimoto S, and Ogihara T. Nitric oxide induced upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension 27: 823-826, 1996.
12. Garg UC and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777, 1989.
13. Gjertsen BT, Mellgren G, Otten A, Maronde E, Genieser HG, Jastorff B, Vintermyr OK, McKnight GS, and Doskeland SO. Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action. J Biol Chem 35: 20599-20607, 1995.
14. Hardman JG and Sutherland EW. Guanylyl cyclase, an enzyme catalyzing the formation of guanosine 3′,5′-monophosphate from guanosine triphosphate. J Biol Chem 244: 6363-6370, 1969.
15. 1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
16. Ignarro LJ, Buga GM, Wood KS, Byrns RE, and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269, 1989.
17. Inscho EW, Belott TP, Mason MJ, Smith JB, and Navar LG. Extracellular ATP increases cytosolic calcium in cultured rat renal arterial smooth muscle cells. Clin Exp Pharmacol 23: 503-507, 1996.
18. Waf1by nitric oxide-generating vasodilator in vascular smooth muscle cells. J Biol Chem 272: 10050-10057, 1997.
19. waf1/Cip1/Sdi1 in vascular smooth muscle cells. Mol Pharmacol 56: 938-946, 1999.
20. Janssens S, Flaherty D, Nong Z, Vareene O, Van PN, Haustermans C, Zoldhelyi P, Gerard R, and Collen D. Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. Circulation 97: 1274-1281, 1998.
21. Jiang H, Colbran JL, Francis SH, and Corbin JD. Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J Biol Chem 267: 1015-1019, 1992.
22. Jiang L, Foster FM, Ward P, Tasevski V, Luttrell BM, and Conigrave AD. Extracellular ATP triggers cyclic AMP-dependent differentiation of HL-60 cells. Biochem Biophys Res Commun 232: 626-630, 1997.
23. Kariya K, Kawahara Y, Araki S, Fukuzaki H, and Tadai Y. Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis 80: 143-147, 1989.
24. Katsuki S, Arnold WP, Mittal CK, and Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerine and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and dydroxylamine. J Cyclic Nucleotide Res 3: 23-35, 1977.
25. Kibbe MR, Li J, Nie S, Watkins SC, Lizonova A, Kovesdi I, Simmons RL, Billiar TR, and Tzeng E. Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate. J Vasc Surg 31: 1214-1228, 2000.
26. Kibbe MR, Nie S, Seol DW, Kovesdi I, Lizonova A, Madaroun M, Billiar TR, and Tzeng E. Nitric oxide prevents p21 degradation with the ubiquitin-proteasome pathway in vascular smooth muscle cells. J Vasc Surg 31: 364-374, 2000.
27. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
28. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, and Jacks T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Gene Devel 9: 935-944, 1995.
29. Mannick JB, Miao XQ, and Stamler JS. Nitric oxide inhibits Fas-induced apoptosis. J Biol Chem 272: 24125-24128, 1997.
30. Ooboshi H, Chu Y, Rios CD, Faraci FM, Davidson BL, and Heistad DD. Altered vascular function after adenovirus-mediated overexpression of endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol 273: H265-H270, 1997.
31. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362: 801-809, 1993.
32. Sato J, Nair K, Hiddinga J, Eberhardt NL, Fitzpatrick LA, Katusic ZS, and O'Brien T. eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis. Cardiovasc Res 47: 697-706, 2000.
33. Sharma RV, Tan E, Fang S, Gurjar MV, and Bhalla RC. NOS gene transfer inhibits expression of cell cyclic regulatory molecules in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 276: H1450-H1459, 1999.
34. Tanner FC, Meier P, Greutert H, Champion C, Nabel EG, and Lüscher TF. Nitric oxide modulates expression of cell cycle regulatory proteins. A cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation 101: 1982-1989, 2000.
35. Varenne O, Pislaru S, Gillijns H, Van PN, Gerard RD, Zoldhelyi P, Van DW, Collen D, and Janssens SP. Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation 98: 919-926, 1998.
36. Von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, and Dzau VJ. Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 92: 1137-1141, 1995.
37. Yang ZY, Simari RD, Perkins ND, San H, Gordon D, Nabel GJ, and Nabel EG.; Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci USA 93: 7905-7910, 1996.